System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Kenneth R Chapman is an expert in Pulmonology at Toronto Western Hospital (Canada). As of October 2026, ScienceLeadR ranks Kenneth R Chapman in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Kenneth R Chapman has authored 533 publications, the most recent in 2026, and is an investigator in 27 clinical trials, 2 of them ongoing. SLR score: 1,936 (community average: 125). How the SLR is computed.

LeadR Profile

Kenneth R Chapman Toronto Western Hospital Canada
1 936 ScienceLeadR Reputation 1936

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Immunology - Critical Care - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1989 - 2026
Source: PubMed

Toronto Western Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 533

Citations

Citations: 23 974 1st author: 121 Last author: 108 Unique author: 29

Main journals

Chest 65
Am J Respir Crit Care Med 30
Neuromodulation 29
Can Respir J 23
05.01 - Airway pharmacology and treatment 22

Best Journals

N Engl J Med 7
Lancet Respir Med 4
Am J Respir Crit Care Med 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Health utilities in individuals with alpha-1 antitrypsin deficiency with and without COPD from the EARCO registry.
PMID 42841174 — registries, quality of life, lung, alpha 1-antitrypsin deficiency, pulmonary disease, chronic obstructive, alpha 1-antitrypsin		Pulmonology20260
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.
PMID 42638984 — therapeutics, asthma		J Asthma Allergy20260
Dissociation of the Hepatic and Pulmonary Axes in Alpha-1 Antitrypsin Deficiency: Independent Trajectories of Organ-Specific Disease.
PMID 42509734 — lung, body mass index, pulmonary emphysema, alpha 1-antitrypsin deficiency, liver, alpha 1-antitrypsin		Biomolecules20260
Normative reference equations for leg discomfort during incremental cardiopulmonary cycle exercise testing in older adults.
PMID 42489397 — exercise, research design, physiology, exercise test, diagnostic imaging		Clin Physiol Funct Imaging20260
Long-term efficacy of dupilumab versus tezepelumab in asthma: a matching-adjusted indirect comparison.
PMID 41747935 — hospitalization, hypersensitivity, therapeutics, asthma		J Allergy Clin Immunol Pract20262

Clinical Studies 27

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 14
Phase 4 7
N/A 4
Phase 2 2

By status:

Completed 23
Active not recruiting 3
Unknown 1

By type:

Interventional 26
Observational 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 2
multicentricup10 21

Main Topics

Cohort/Consortium Investigators 8

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study to Assess the Efficacy Safety and Tolerability of NOC 110 in Adults With Refractory or Unexplained Chronic Cough
NCT06504446 — safety, powders, inhalation, cough, chronic cough		Phase 2Active not recruiting2024
Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain
NCT05103527 — joint diseases, chronic pain, osteoarthritis, knee, pain, arthritis, osteoarthritis, ganglia, spinal, therapeutics, ganglion cysts, spine		N/AActive not recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS